§ Honest Comparison · Updated May 2026

PeptideApprove vs Easy Pay Direct

Both processors will onboard compliant peptide merchants. They differ on pricing transparency, reserve schedule, and what happens when your primary acquirer tightens risk appetite. Here's the honest side-by-side.

§ Verdict

Pick PeptideApprove if you want fixed 5% all-in pricing, faster sponsor-bank review, and simple KYC/KYB onboarding. Pick Easy Pay Direct if you want the longer-established brand and don't mind quote-only pricing or a longer quote-and-compliance cycle.

Feature-by-feature

Side-by-side comparison.

Feature
PeptideApprove
Easy Pay Direct
Industry rate range 5–15% typical for peptide MIDs 5–15%
Serves RUO + Healthcare Both tracks — RUO label-compliance path or LegitScript-certified pharmacy path Healthcare-licensed (LegitScript) only
Pricing model Statement-audited. Published savings vs. your current rate. Quote-only, case-by-case
Reserve schedule Statement-audited. Released on a published schedule. 10–15% / 180 days
LegitScript bundled at cost Yes — $1,075/year at-cost, no markup Required, not bundled
Two pre-underwritten backends Yes — primary + warm backup MID No — single acquirer
Onboards MATCH-listed merchants Yes, with documented cause + LegitScript No — declines MATCH
Onboarding (compliant merchant) 10 days 4–6 weeks
Application fee $0 Varies
Early termination fee $0 Contract-dependent
Won't onboard guarantee If we can't lower your TCO, we won't onboard you
Statement audit Yes — itemized, 24-hour turnaround Not offered
Contact channel Web application + email Web application + phone
Established 2026 2014

The honest assessment

Where each one actually wins.

PeptideApprove wins on:

  • Pricing transparency. Statement-audited pricing means you see the exact line-item delta before signing. Easy Pay Direct quotes case-by-case, which is conventional in high-risk but leaves room for interpretation.
  • Reserve schedule. Our reserve is released on a documented, published schedule. Easy Pay Direct's reserve is closer to the industry default of 10–15% held 180 days, which strangles working capital.
  • Backup acquirer. PeptideApprove focuses on faster sponsor-bank review, fixed 5% all-in pricing, and payout flexibility. Easy Pay Direct is a longer-established brand, but its pricing and approval path can be less direct.
  • LegitScript handling. We bundle the $1,075 at-cost and pre-screen your site to clear in 2–3 weeks. Easy Pay Direct requires LegitScript but doesn't bundle the cost or shepherd the certification.
  • Onboarding speed. 10 days vs. 4–6 weeks. The difference is one document checklist (us) vs. multiple back-and-forth rounds (industry standard).

Easy Pay Direct wins on:

  • Brand longevity. Easy Pay Direct has been in the high-risk processing space since 2014. PeptideApprove launched in 2026. If brand age is your tiebreaker, EPD has more years on the books.
  • Phone-first service. EPD takes inbound sales calls. PeptideApprove is web-app + email until you've seen your quote — by design. If you prefer to talk to a sales rep before seeing a rate, EPD is the warmer experience.
  • Cross-category exposure. EPD processes for nutraceuticals, supplements, CBD, and several other high-risk categories — not just peptides. If your portfolio spans categories, that breadth matters. PeptideApprove is peptide-only by design.

Decision guide

Which one should you actually pick?

If you've already been terminated by Stripe or Shopify

Both will onboard you. PeptideApprove will quote you in one business day; EPD in 4–6 weeks. If cash flow matters, the difference is material.

If you're on the MATCH list

PeptideApprove. EPD declines MATCH applications. We can onboard with documented cause + a LegitScript certification path.

If you process across multiple high-risk categories

EPD. We're peptide-only. If you sell peptides AND supplements AND something else, EPD's cross-category exposure is the better fit.

If working capital efficiency matters

PeptideApprove. Our 90-day published reserve releases capital ~2× faster than the 180-day industry-default that EPD typically runs.

If you've never had a processor terminate you and you don't anticipate one will

Either works. But the question becomes whether you want a backup acquirer warm and waiting (PeptideApprove) or a single-MID setup (EPD). Most peptide founders who have been processing for 24+ months have been surprised at least once.

Send us your current statement. We'll show you what you'd save.

Side-by-side analysis in your inbox within 24 hours. No phone calls. No application fee. If we can't lower your total cost of ownership in year one, we won't onboard you.